Daily non-political popular news in brief.

'Triple negative' breast cancers linked to the young, minority

A new study suggests that triple negative tumors are more common among women who are African American and Hispanic, under 40 years old, and who have lower socioeconomic status (SES). The study found triple negative tumors are also associated with later diagnosis and shorter survival.

Read more »

Keywords: triple, negative, breast, cancers, linked, young, minority, cancer

« Previous | Next »

Similar news on "'Triple negative' breast cancers linked to the young, minority":

1. BRCA1 mutation linked to breast cancer stem cells
   01-31-2008 · EurekAlert!
   A new study may explain why women with a mutation in the BRCA1 gene face up to an 85 percent lifetime risk of breast cancer. Researchers from the University of Michigan Comprehensive Cancer Center found that BRCA1 plays a role in regulating breast stem cells, the small number of cells that might develop into cancers.
   Similar news · Read more »
   
2. Why cisplatin kills breast cancer cells when other drugs fail
   04-19-2007 · EurekAlert!
   The cancerous cells of some individuals with breast cancer lack expression of two cell surface proteins, the estrogen and progesterone receptors, and do not express increased amounts of HER2. Individuals with such breast cancer (known as triple-negative breast cancer) do not respond to treatment with commonly used chemotherapeutic drugs and their prognosis is relatively poor. But a new study has indicated why triple-negative breast cancer cell lines are sensitive to exposure to the chemotherapeutic cisplatin.
   Similar news · Read more »
   
3. Screening approach leads to discovery of gene linked to breast cancer
   06-14-2007 · EurekAlert!
   Using a novel three-part screening process, scientists at Dana-Farber Cancer Institute have identified a gene that is made inappropriately in about a third of all breast cancers. The discovery, reached in collaboration with researchers at Brigham and Women’s Hospital (BWH) and the Broad Institute of Harvard and MIT, is reported in the June 15, 2007 issue of the journal Cell.
   Similar news · Read more »
   
4. Src inhibitors may prove beneficial in breast cancer therapy
   07-12-2007 · EurekAlert!
   Estrogen, which binds estrogen receptor alpha (ER-alpha), is a risk factor for breast cancer development. However, one-third of new breast cancers lack detectable ER-alpha. These ER-alpha-negative cancers are more aggressive and have a worse prognosis than do ER-alpha-positive breast cancers, and have been thought to be estrogen independent. In a new JCI study, University of Miami researchers shed further light on the mechanisms regulating ER-alpha expression levels during breast cancer.
   Similar news · Read more »
   
5. Molecular signature may identify cisplatin-sensitive breast tumors
   04-19-2007 · EurekAlert!
   Researchers at the Massachusetts General Hospital Cancer Center have identified a subgroup of hard-to-treat breast cancers that may be sensitive to the drug cisplatin, rarely used in the treatment of breast tumors. They also have discovered the molecular basis of this sensitivity, which may help identify patients most likely to benefit from cisplatin treatment.
   Similar news · Read more »
   
6. Linchpin gene may be useful target for new breast cancer therapies
   09-15-2007 · EurekAlert!
   University of Iowa researchers have discovered a gene that plays a linchpin role in the ability of breast cancer cells to respond to estrogen. The finding may lead to improved therapies for hormone-responsive breast cancers, and may explain differences in the effectiveness of current treatments.
   Similar news · Read more »
   
7. Genome update defines landscape of breast and colon cancers
   10-11-2007 · EurekAlert!
   One year after completing the first large-scale report sequencing breast and colon cancer genes, Johns Hopkins Kimmel Cancer Center scientists have studied the vast majority of protein-coding genes which now suggest a landscape dominated by genes that each are mutated in relatively few cancers.
   Similar news · Read more »
   
8. Chemotherapy temporarily affects the structures of the human brain
   11-27-2006 · EurekAlert!
   Researchers have linked chemotherapy with short-term structural changes in cognitive areas of the brain, according to a new study. The study reveals that within 12 months of receiving adjuvant chemotherapy, significant regions of the brain associated with memory, analysis and other cognitive functions were significantly smaller in breast cancer patients who received chemotherapy than those who did not.
   Similar news · Read more »
   
9. Cancer stem cells can go it alone
   06-11-2007 · EurekAlert!
   At the heart of most, if not all cancers, lie a handful of wayward stem cells that feed the ever growing tumor mass, but their scarcity make it difficult for scientists to study them. Now, times of plenty may lie ahead as a breast cancer cell line -- established long ago -- turned out to behave a lot like cancer stem cells.
   Similar news · Read more »
   
10. Sentinel lymph node biopsy is associated with breast cancer rates
    06-26-2007 · EurekAlert!
    The incidence of some early stage metastatic breast cancers is increasing, but this finding is likely explained by changes in clinical practice, according to a study published online June 26 in the Journal of the National Cancer Institute.
    Similar news · Read more »